Whitehawk Therapeutics (WHWK) Current Leases (2019 - 2024)
Whitehawk Therapeutics' (WHWK) quarterly Current Leases came in at $268000.0 in Q4 2024, down 38.25% year-on-year from $434000.0 in Q1 2024, and down 16.77% on a QoQ basis from $322000.0 in Q3 2024.
Whitehawk Therapeutics (WHWK) Current Leases (2019 - 2024) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 6 years of Current Leases data on file, last reported at $268000.0 in Q4 2024.
- On a quarterly basis, Current Leases fell 38.25% year-over-year to $268000.0 in Q4 2024; TTM through Dec 2024 was $268000.0, a 38.25% decrease from a year earlier, with the FY2024 full-year figure at $268000.0, down 38.25% from the prior year.
- Current Leases for Q4 2024 stood at $268000.0, down from $322000.0 in the prior quarter.
- Over the last five years, Current Leases for WHWK reached as high as $434000.0 in Q4 2023 and fell as low as $9955.0 in Q2 2021.
- Historically, Current Leases has averaged $251285.0 across 5 years, with a median of $295000.0 in 2024.
- Across the five-year window, Current Leases plunged 91.04% in 2021 and jumped 3154.65% in 2022, its largest moves.
- Year by year, Current Leases stood at $125000.0 in 2020, then increased by 4.8% to $131000.0 in 2021, then surged by 200.76% to $394000.0 in 2022, then increased by 10.15% to $434000.0 in 2023, then sank by 38.25% to $268000.0 in 2024.
- Per Business Quant data, the three most recent Current Leases figures were $268000.0 in Q4 2024, $322000.0 in Q3 2024, and $374000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Whitehawk Therapeutics | 34.18 Mn | 34.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 268,000.00 |
| Sep 30, 2024 | 322,000.00 |
| Jun 30, 2024 | 374,000.00 |
| Mar 31, 2024 | 425,000.00 |
| Dec 31, 2023 | 434,000.00 |
| Sep 30, 2023 | 423,000.00 |
| Jun 30, 2023 | 413,000.00 |
| Mar 31, 2023 | 404,000.00 |
| Dec 31, 2022 | 394,000.00 |
| Sep 30, 2022 | 374,000.00 |
| Jun 30, 2022 | 324,000.00 |
| Mar 31, 2022 | 163,000.00 |
| Dec 31, 2021 | 131,000.00 |
| Sep 30, 2021 | 90,000.00 |
| Jun 30, 2021 | 9,955.00 |
| Mar 31, 2021 | 39,171.00 |
| Dec 31, 2020 | 125,000.00 |
| Sep 30, 2020 | 94,787.00 |
| Jun 30, 2020 | 111,053.00 |
| Mar 31, 2020 | 106,734.00 |